Cargando…

Chemotherapy for advanced pulmonary sarcomatoid carcinoma: a population-based propensity score matching study

OBJECTIVES: Pulmonary sarcomatoid carcinoma (PSC) is a rare histological type of non-small cell lung cancer (NSCLC). There are no specific treatment guidelines for PSC. For advanced PSC (stage II-IV), the role of chemotherapy is still controversial. The purpose of this study was to investigate the e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Feng, Yu, Xiangyang, Han, Yi, Gong, Changfan, Yan, Dongjie, Yang, Lei, Li, Jie, Liu, Shuku
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350265/ https://www.ncbi.nlm.nih.gov/pubmed/37454075 http://dx.doi.org/10.1186/s12890-023-02541-1

Ejemplares similares

Additional chemotherapy improves survival in stage II–III pulmonary sarcomatoid carcinoma patients undergoing surgery: a propensity scoring matching analysis
por: Cen, Yanhong, et al.
Publicado: (2021)

Evaluation of the necessity of Pulmonary Ligament Lymph Node Dissection for Upper Lobe Stage IB NSCLC: A Propensity Score-matched Study
por: Wang, Feng, et al.
Publicado: (2022)

The Necessity of Anti-Tuberculosis Therapy after Resection of Pulmonary Tuberculous Nodules: A Single Center Retrospective Study
por: Wang, Chong, et al.
Publicado: (2019)

Prognostic value of the sarcomatoid component in bladder cancer: A propensity score matching study
por: Liu, Shuai, et al.
Publicado: (2023)

MET alterations in advanced pulmonary sarcomatoid carcinoma
por: Gong, Chen, et al.
Publicado: (2022)

Definitive Chemoradiotherapy for Advanced Pulmonary Sarcomatoid Carcinoma
por: Takeda, Kazuya, et al.
Publicado: (2016)

Immunophenotyping of pulmonary sarcomatoid carcinoma
por: Ma, Yu, et al.
Publicado: (2022)

Optimize the number of cycles of induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma: a propensity score matching analysis
por: Jiang, YuTing, et al.
Publicado: (2022)

Propensity-score matched comparison of partial versus radical nephrectomy for T1N0M0 sarcomatoid renal cell carcinoma
por: Ji, Bing, et al.
Publicado: (2020)

Comparing the efficacy of induction-concurrent with concurrent-adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma: a propensity score matching analysis
por: Wu, Li-Rong, et al.
Publicado: (2017)

Propensity-score-matching-based analysis of laparoscopic gastrectomy with neoadjuvant chemotherapy for gastric carcinoma
por: Furuta, Shimpei, et al.
Publicado: (2021)

Effect of induction chemotherapy with cisplatin, fluorouracil, with or without taxane on locoregionally advanced nasopharyngeal carcinoma: a retrospective, propensity score-matched analysis
por: Liu, Guo-Ying, et al.
Publicado: (2018)

Safety and Feasibility of Esophagectomy Following Combined Immunotherapy and Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Propensity Score Matching Analysis
por: Hong, Zhi-Nuan, et al.
Publicado: (2022)

Pulmonary sarcomatoid carcinoma: Future prospects of adjuvant immunotherapy in advanced management
por: Agrawal, Anand
Publicado: (2020)

The role of radiotherapy in pulmonary large cell neuroendocrine carcinoma: propensity score matching analysis
por: Cao, Ling, et al.
Publicado: (2020)

Chemotherapy versus Best Supportive Care in Advanced Biliary Tract Carcinoma: A Multi-institutional Propensity Score Matching Analysis
por: Ji, Jun Ho, et al.
Publicado: (2018)

Hepatic Arterial Infusion Chemotherapy with Cisplatin versus Sorafenib for Intrahepatic Advanced Hepatocellular Carcinoma: A Propensity Score-Matched Analysis
por: Zaizen, Yuki, et al.
Publicado: (2021)

Docetaxel and cisplatin induction chemotherapy with or without fluorouracil in locoregionally advanced nasopharyngeal carcinoma: A retrospective propensity score matching analysis
por: Tao, Hao‐Yun, et al.
Publicado: (2021)

PREOPERATIVE CHEMOTHERAPY VERSUS UPFRONT SURGERY FOR ADVANCED GASTRIC CANCER: A PROPENSITY SCORE MATCHING ANALYSIS
por: Hong, Stefany, et al.
Publicado: (2023)

Comparison of neoadjuvant immunotherapy plus chemotherapy versus chemotherapy alone for patients with locally advanced esophageal squamous cell carcinoma: A propensity score matching
por: Jing, Shao-Wu, et al.
Publicado: (2022)

Clinical analysis of 78 pulmonary sarcomatoid carcinomas with surgical treatment
por: Gong, Ting, et al.
Publicado: (2022)

Triplet versus doublet neoadjuvant chemotherapy regimens for locally advanced gastric cancer: a propensity score matching analysis
por: Chen, Yonghe, et al.
Publicado: (2021)

Sarcomatoid Carcinoma of the Lung: A Model of Resistance of Chemotherapy
por: Ouziane, Imane, et al.
Publicado: (2014)

Efficacy and Safety of Neoadjuvant Chemotherapy Combined with Adjuvant Chemotherapy for Locally Advanced Colon Cancer: A Propensity Score-Matching Analysis
por: Zeng, Wei, et al.
Publicado: (2022)

The Efficacy of S-1 as Adjuvant Chemotherapy for Resected Biliary Tract Carcinoma: A Propensity Score-Matching Analysis
por: Miyata, Yoichi, et al.
Publicado: (2021)

Clinical value of nedaplatin-based chemotherapy combined with radiotherapy for locoregional advanced nasopharyngeal carcinoma: a retrospective, propensity score-matched analysis
por: Zhan, Ze-Jiang, et al.
Publicado: (2020)

Pulmonary sarcomatoid carcinoma: a case report
por: Shen, Xiao-yong, et al.
Publicado: (2013)

Pulmonary sarcomatoid carcinoma: University of Cincinnati experience
por: Karim, Nagla Abdel, et al.
Publicado: (2017)

Clinical and molecular characteristics of pulmonary sarcomatoid carcinoma
por: Sim, Jae Kyeom, et al.
Publicado: (2018)

Pulmonary sarcomatoid carcinoma: progress, treatment and expectations
por: Li, Xin, et al.
Publicado: (2020)

Approaches to Tumor Classification in Pulmonary Sarcomatoid Carcinoma
por: Baldovini, Chiara, et al.
Publicado: (2019)

Adjuvant chemotherapy for breast cancer after preoperative chemotherapy: A propensity score matched analysis
por: Labrosse, Julie, et al.
Publicado: (2020)

Immune checkpoint inhibitors plus chemotherapy in patients with locally advanced or metastatic pulmonary sarcomatoid carcinoma: a multicentric real-world study
por: Zhou, Fei, et al.
Publicado: (2022)

Effect of Early Adjuvant Chemotherapy on Survival of Advanced Gastric Cancer Patients: a Propensity Score-matched Analysis
por: Lee, Yoontaek, et al.
Publicado: (2018)

Survival Benefit of Perioperative Chemotherapy in Patients with Locally Advanced Gastric Cancer: a Propensity Score Matched Analysis
por: Eom, Bang Wool, et al.
Publicado: (2018)

Synergy of Losartan and chemotherapy for patients with cholangiocarcinoma: A propensity score-matched analysis
por: Li, Qing, et al.
Publicado: (2022)

Transarterial Chemoembolization Combined With Apatinib for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
por: Kan, Xuefeng, et al.
Publicado: (2020)

Modified Glasgow prognostic score predicts the prognosis of patients with advanced esophageal squamous cell carcinoma: A propensity score‐matched analysis
por: Cui, Chanjuan, et al.
Publicado: (2022)

Evaluation of sorafenib treatment and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: a comparative study using the propensity score matching method
por: Fukubayashi, Kotaro, et al.
Publicado: (2015)

A comparison of neoadjuvant chemotherapy with gemcitabine versus docetaxel plus cisplatin in locoregionally advanced nasopharyngeal carcinoma: a propensity score matching analysis
por: Liu, Tongxin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6o826d4htrtiud7jtnlteiggaj